文献速递流行病学与生物统计临床试验与 GCP

高负担环境中结核分枝杆菌全基因组测序用于疾病控制:在马达加斯加农村评估不同社区干预策略的整群随机对照试验研究方案

Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural Madagascar.
PubMed 文献 · Trials · 2024-10-25

该整群随机对照试验将在马达加斯加Vohibato区48个农村村组中比较三种社区结核病干预策略,主要结局为干预1年后每组的年检出病例数/10万。研究旨在确定常规结核分枝杆菌全基因组测序在高发病率环境中对结核病例发现的影响。

要点

  • 48个农村村组随机分为标准诊疗、最佳实践和新型干预三组。
  • 新型干预组在最佳实践基础上增加痰培养和结核分枝杆菌全基因组测序。
  • 主要结局为干预1年后每组的年检出病例数/10万。

核心结论

  • 本研究旨在确定前瞻性全基因组测序分子分型对高发病率环境中结核病例发现是否有影响。
  • 假说认为,调查分子分型提示的潜在暴发并在时空上聚焦主动病例发现可改善农村社区的病例发现。

研究设计与样本

  • 整群随机对照试验,在马达加斯加Vohibato区48个农村村组(Fokontany)中开展。
  • 村组随机分配至三种干预组之一,干预观察期为2年。

主要发现

  • 第1组(标准诊疗)采用基于卫生机构的被动病例发现和涂片显微镜检查。
  • 第2组(最佳实践)包括主动病例发现和Xpert MTB/RIF Ultra PCR检测,随后进行家庭接触者调查。
  • 第3组(新型干预)包括与第2组相同的干预,并增加对所有新诊断病例的痰培养和结核分枝杆菌全基因组测序;对分子分型提示的潜在暴发进行调查,并对其他结核疑似者进行适当检测。
  • 主要结局为干预1年后每组的年检出病例数/10万。

局限性

  • 试验注册为回顾性注册(ClinicalTrials.gov NCT05406453,注册日期2022年6月6日)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Retrospective and descriptive molecular epidemiology studies have shown that Mycobacterium tuberculosis whole genome sequencing can identify outbreaks and disease transmission events with higher resolution than conventional epidemiological investigations. Those studies have strengthened our understanding of genomic polymorphisms correlating with person-to-person transmission and helped resolve putative transmission clusters. To date, systematic genomic surveillance programs implemented for M. tuberculosis were only implemented in low-incidence settings. The purpose of this study is to determine whether there is an impact of routine M. tuberculosis whole genome sequencing on tuberculosis case detection in a high-incidence setting. METHODS: A cluster randomized controlled trial will be performed. Forty-eight rural village groups (or Fokontany) in the Vohibato district of Madagascar will be randomized to one of three interventions arms. Arm 1 (standard of care) involves healthcare facility-based passive case detection with smear microscopy testing. Arm 2 (best practice) consists of active case finding and Xpert MTB/RIF Ultra PCR testing followed by household contact investigations. Arm 3 (novel intervention) includes the same interventions as arm 2, with addition of sputum culture and M. tuberculosis whole genome sequencing for all newly diagnosed cases. In arm 3, molecular suggested putative outbreaks are investigated, and additional TB suspects are appropriately tested. The intervention observational period will be 2 years. The primary outcome will be the number of detected cases/100,000/year in each arm after 1 year of intervention. DISCUSSION: This study is designed to determine whether there is an impact of prospective whole genome sequencing-based molecular typing on tuberculosis case detection in high-incidence settings. Investigating potential outbreaks and focusing active case finding in spatiotemporal settings where disease transmission is suggested by genomic typing is hypothesized to improve case detection in rural communities. TRIAL REGISTRATION: ClinicalTrials.gov NCT05406453 . Retrospectively registered on June 6, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ametepe ESA, Andriamanoha N, Andrianomanana FR, et al. Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural Madagascar. Trials. 2024. PMID: 39456079. doi:10.1186/s13063-024-08537-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。